About Brandon Capital Partners
Brandon Capital Partners makes seed and venture capital investments to support the development and international growth of Australian life science companies. The firm works collaboratively with entrepreneurs to demonstrate the benefit of their technology, thereby creating value for them, their teams and investors.
Brandon Capital Partners Headquarter Location
Level 1 257 Collins Street
Melbourne, Victoria, 3000,
+61 3 9657 0700
Latest Brandon Capital Partners News
Sep 16, 2021
Allay Therapeutics, a clinical-stage biotechnology company pioneering ultra-sustained analgesic products to transform post-surgical pain management and recuperation, announced the completion of its oversubscribed $60M Series C financing, led by Arboretum Ventures. Participating in the round were NEA, Temasek, Pavilion Capital, Brandon Capital Partners, Vertex Growth, Vertex Ventures HC, and WTT Investment Ltd. (c)2011-2020 by Massinvestor, Inc. For contact info, please check out our about page.
Brandon Capital Partners Team
5 Team Members
Brandon Capital Partners has 5 team members, including current Chief Financial Officer, Kerensa Argyriou.